Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964372014> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W1964372014 abstract "The MAP Kinase pathway is commonly dysregulated in cancer. We have developed the use of a highly sensitive microfluidic nano‐immunoassay system (NIA) to perform detailed analysis of ERK and MEK activation in hematopoietic and solid tumors. We recently reported use of NIA for measurement of proteins in as little as 4 nanoliters of lysate from preclinical and clinical lymphoma and leukemia specimens (Fan et al, Nature Medicine 2009). Now, we present results measuring specific isoforms of MAP Kinase proteins in cells sampled from patients with solid tumors and Myelodysplastic Syndrome (MDS). First, we developed tissue collection, handling and processing protocols to produce reliable NIA results in a small number of cells obtained by minimally invasive techniques. We collected over 100 blood buffy coat and fine needle aspirate (FNA) specimens from normal controls and patients with MDS or solid tumors. Using a single antibody that recognizes both the phosphorylated and unphosphorylated isoforms of ERK, we can determine not only relative levels of phosphorylated isoforms of ERK protein, but also calculate the percent phosphorylation of ERK in each clinical specimen. We have developed a similar method to quantify MEK isoforms. NIA revealed that adenocarcinoma, squamous cell carcinoma, renal cell carcinoma, and MDS samples could be distinguished from non‐tumor specimens based upon different patterns of phosphorylated ERK isoforms. To determine if signaling changes can be detected by NIA upon treatment of cells with novel targeted therapies, human leukemic TF1 cells were treated with a polo‐1 kinase (PLK‐1) inhibitor, ON01910 (Onconova, Inc.). We found the surprising result that only 5% of ERK1 and ERK2 were found to be phosphorylated in the TF1 cell line, whereas 45% and 90% of MEK1 and MEK2 were phosphorylated, respectively. Additionally, NIA analysis revealed a 20% decrease in the percent of phosphorylated MEK2 after treatment with ON01910. Taken together, our studies demonstrate that NIA can be used to identify specific changes in MAPK signaling pathway that distinguish normal from malignant cells as well as quantitatively measure the response of malignant cells to a targeted therapeutic. Citation Information: Mol Cancer Ther 2009;8(12 Suppl):B178." @default.
- W1964372014 created "2016-06-24" @default.
- W1964372014 creator A5010630509 @default.
- W1964372014 creator A5022335574 @default.
- W1964372014 creator A5025845901 @default.
- W1964372014 creator A5028169162 @default.
- W1964372014 creator A5030754548 @default.
- W1964372014 creator A5040612375 @default.
- W1964372014 creator A5041683169 @default.
- W1964372014 creator A5053471189 @default.
- W1964372014 creator A5055624947 @default.
- W1964372014 creator A5067230315 @default.
- W1964372014 creator A5069550037 @default.
- W1964372014 creator A5077066907 @default.
- W1964372014 creator A5086672010 @default.
- W1964372014 date "2009-12-10" @default.
- W1964372014 modified "2023-09-26" @default.
- W1964372014 title "Abstract B178: Nanoscale quantification of phosphorylated and unphosphorylated ERK and MEK isoforms differentiates tumor and nontumor clinical specimens" @default.
- W1964372014 doi "https://doi.org/10.1158/1535-7163.targ-09-b178" @default.
- W1964372014 hasPublicationYear "2009" @default.
- W1964372014 type Work @default.
- W1964372014 sameAs 1964372014 @default.
- W1964372014 citedByCount "1" @default.
- W1964372014 countsByYear W19643720142012 @default.
- W1964372014 crossrefType "proceedings-article" @default.
- W1964372014 hasAuthorship W1964372014A5010630509 @default.
- W1964372014 hasAuthorship W1964372014A5022335574 @default.
- W1964372014 hasAuthorship W1964372014A5025845901 @default.
- W1964372014 hasAuthorship W1964372014A5028169162 @default.
- W1964372014 hasAuthorship W1964372014A5030754548 @default.
- W1964372014 hasAuthorship W1964372014A5040612375 @default.
- W1964372014 hasAuthorship W1964372014A5041683169 @default.
- W1964372014 hasAuthorship W1964372014A5053471189 @default.
- W1964372014 hasAuthorship W1964372014A5055624947 @default.
- W1964372014 hasAuthorship W1964372014A5067230315 @default.
- W1964372014 hasAuthorship W1964372014A5069550037 @default.
- W1964372014 hasAuthorship W1964372014A5077066907 @default.
- W1964372014 hasAuthorship W1964372014A5086672010 @default.
- W1964372014 hasConcept C104317684 @default.
- W1964372014 hasConcept C11960822 @default.
- W1964372014 hasConcept C121608353 @default.
- W1964372014 hasConcept C126322002 @default.
- W1964372014 hasConcept C184235292 @default.
- W1964372014 hasConcept C2781249067 @default.
- W1964372014 hasConcept C502942594 @default.
- W1964372014 hasConcept C53345823 @default.
- W1964372014 hasConcept C55493867 @default.
- W1964372014 hasConcept C57074206 @default.
- W1964372014 hasConcept C71924100 @default.
- W1964372014 hasConcept C86803240 @default.
- W1964372014 hasConcept C95444343 @default.
- W1964372014 hasConceptScore W1964372014C104317684 @default.
- W1964372014 hasConceptScore W1964372014C11960822 @default.
- W1964372014 hasConceptScore W1964372014C121608353 @default.
- W1964372014 hasConceptScore W1964372014C126322002 @default.
- W1964372014 hasConceptScore W1964372014C184235292 @default.
- W1964372014 hasConceptScore W1964372014C2781249067 @default.
- W1964372014 hasConceptScore W1964372014C502942594 @default.
- W1964372014 hasConceptScore W1964372014C53345823 @default.
- W1964372014 hasConceptScore W1964372014C55493867 @default.
- W1964372014 hasConceptScore W1964372014C57074206 @default.
- W1964372014 hasConceptScore W1964372014C71924100 @default.
- W1964372014 hasConceptScore W1964372014C86803240 @default.
- W1964372014 hasConceptScore W1964372014C95444343 @default.
- W1964372014 hasLocation W19643720141 @default.
- W1964372014 hasOpenAccess W1964372014 @default.
- W1964372014 hasPrimaryLocation W19643720141 @default.
- W1964372014 hasRelatedWork W1513475668 @default.
- W1964372014 hasRelatedWork W1591376091 @default.
- W1964372014 hasRelatedWork W2002062371 @default.
- W1964372014 hasRelatedWork W2005815300 @default.
- W1964372014 hasRelatedWork W2023437839 @default.
- W1964372014 hasRelatedWork W2060421587 @default.
- W1964372014 hasRelatedWork W2067435246 @default.
- W1964372014 hasRelatedWork W2104928407 @default.
- W1964372014 hasRelatedWork W2131543523 @default.
- W1964372014 hasRelatedWork W2185717437 @default.
- W1964372014 hasRelatedWork W2328171895 @default.
- W1964372014 hasRelatedWork W2333309954 @default.
- W1964372014 hasRelatedWork W2558069668 @default.
- W1964372014 hasRelatedWork W2580774737 @default.
- W1964372014 hasRelatedWork W2606965722 @default.
- W1964372014 hasRelatedWork W2780841137 @default.
- W1964372014 hasRelatedWork W2885704264 @default.
- W1964372014 hasRelatedWork W2886444643 @default.
- W1964372014 hasRelatedWork W3167895848 @default.
- W1964372014 hasRelatedWork W2740804106 @default.
- W1964372014 isParatext "false" @default.
- W1964372014 isRetracted "false" @default.
- W1964372014 magId "1964372014" @default.
- W1964372014 workType "article" @default.